Literature DB >> 10497638

Sonographic evaluation of induced abortion--experience in Nigeria.

V A Adetiloye1, F O Dare.   

Abstract

A sonographic evaluation of forty-six patients with suspected complications of unsafe induced abortion was performed prospectively. The sonographic features were correlated with surgical findings. Based on the sonographic findings, the patients were categorised into three groups. There was no clear association between the severity of sonographic or pathological findings and the time of presentation for ultrasound after the termination of pregnancy, but most of the patients presenting after 5 days belonged to groups II and III, i.e. had uterine complications with or without abdomino-pelvic complications. The commonest complication, sepsis, is variably expressed sonographically in all groups. Although, the sonographic appearances of sepsis are similar to those seen in pelvic inflammatory disease (PID), some features seen with post-abortal sepsis are peculiar. Apart from sepsis, other complications of abortion presented non-specific sonographic features. "Pseudouterus" appearance was demonstrated in one patient after hysterectomy. The likelihood of pre-operative diagnosis of uterine perforation is high when the presentation is early before the formation of complex echopatterns of sepsis or in the absence of free intraperitoneal gas from bowel perforation or gas-forming organism. Routing manual vacuum aspiration or therapeutic endometrial curettage is unnecessary where sonography shows no evidence of retained products post abortion.

Entities:  

Mesh:

Year:  1998        PMID: 10497638

Source DB:  PubMed          Journal:  Afr J Med Med Sci        ISSN: 0309-3913


  1 in total

1.  Spectrum of diseases and diagnostic values of ultrasound in adult patients with nontraumatic acute abdomen in a nigerian tertiary health facility.

Authors:  Bimbo Ayoola Ashaolu; Mopelola Christianah Asaleye; Adebayo Victor Adetiloye; Isaac Olusegun Alatise
Journal:  Niger J Surg       Date:  2015 Jan-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.